Author:
Liam Chong-Kin,Wahid Mohamed Ibrahim A.,Rajadurai Pathmanathan,Cheah Yoke-Kqueen,Ng Tiffany Shi-Yeen
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference41 articles.
1. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers;Shigematsu;J Natl Cancer Inst,2005
2. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib;Jackman;Clin Cancer Res,2006
3. [Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer];Liu;Zhonghua Yi Xue Yi Chuan Xue Za Zhi,2007
4. [The predictive value of EGFR status in non-small cell lung cancer patients treated with EGFR-TKIs];Wang;Zhongguo Fei Ai Za Zhi,2010
5. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets;Cohen;Oncologist,2003
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献